Raymond James Financial Services Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-22,409
Closed -$53.6K 3455
2023
Q3
$53.6K Hold
22,409
﹤0.01% 3147
2023
Q2
$51.8K Hold
22,409
﹤0.01% 3129
2023
Q1
$57.1K Hold
22,409
﹤0.01% 3121
2022
Q4
$56.2K Hold
22,409
﹤0.01% 3075
2022
Q3
$65K Sell
22,409
-2,000
-8% -$8.42K ﹤0.01% 3062
2022
Q2
$110K Buy
24,409
+2,000
+9% +$11.9K ﹤0.01% 3001
2022
Q1
$180K Buy
22,409
+10,989
+96% +$96.9K ﹤0.01% 2997
2021
Q4
$133K Sell
11,420
-4,989
-30% -$59.7K ﹤0.01% 3076
2021
Q3
$203K Buy
+16,409
New +$185K ﹤0.01% 2975

Other funds holding SLGC

Raymond James Financial Services Advisors's SLGC Position: Q4 2023 in Review

Raymond James Financial Services Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 22,409 shares — an estimated $53.6K sold.

Raymond James Financial Services Advisors first reported a position in SLGC in Q3 2021 and held it in 9 quarters. The position peaked at $203K in Q3 2021. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Raymond James Financial Services Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 22,409 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $53.6K.
  • Raymond James Financial Services Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 9 quarters.
  • Raymond James Financial Services Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $203K in Q3 2021.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.